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DIETARY METHIONINE RESTRICTION SIGNALS TO THE BRAIN
THROUGH FGF21 TO REGULATE ENERGY BALANCE AND
REMODELING OF ADIPOSE TISSUE
LA Forney1,2, H Fang1, LC Sims1, KP Stone1, LY Vincik, AM Vick1, AN Gibson, DH Burk1,
TW Gettys1
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1Laboratory

of Nutrient Sensing & Adipocyte Signaling, Pennington Biomedical Research Center,
Baton Rouge, LA

Abstract
Objective: Restricting dietary methionine to 0.17% in mice increases energy expenditure,
reduces fat deposition, and improves metabolic health by increasing hepatic FGF21. The goal was
to compare each of these responses in mice with the co-receptor for FGF21 deleted in either
adipose tissue or the brain.
Methods: Methionine-restricted (MR) diets were fed to age-matched cohorts of mice with the
co-receptor for FGF21 deleted in either adipose tissue or the brain. The physiological and
transcriptional responses to MR were compared in the respective cohorts.
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Results: Tissue-specific deletion of the FGF21 co-receptor in adipose tissue did not abrogate the
ability of dietary MR to increase energy expenditure and reduce fat deposition. Tissue-specific
deletion of the FGF21 co-receptor from the brain produced mice that were unable to respond to
the effects of MR on energy expenditure or the remodeling of adipose tissue.
Conclusions: The increase in FGF21 produced by dietary MR acts primarily in the brain to
produce its physiological effects on energy balance. In contrast, the effects of MR on hepatic gene
expression were intact in both models, supporting a mechanism that directly links detection of
reduced methionine in the liver to transcriptional mechanisms that alter gene expression in the
liver.
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Introduction
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Dietary methionine restriction (MR) represents an appealing approach to treat obesity
because it produces weight loss without food restriction. It does this by activating
transcriptional programs of thermogenesis in brown and white adipose tissue that enhance
uncoupled fat oxidation while producing a persistent increase in total energy expenditure
(EE) (1–4). The cumulative effect of increased EE limits ongoing fat deposition, and in
conjunction with transcriptional changes that reduce hepatic lipid synthesis, dietary MR
produces a coordinated improvement in multiple biomarkers of metabolic health (5–8). An
important advance in understanding how dietary MR produces these effects came with the
observation that within hours of its introduction, dietary MR produces a significant increase
in hepatic expression and release of the hormone, fibroblast growth factor 21 (FGF21) into
the circulation (5, 9). In subsequent loss-of-function studies with FGF21-null mice, it was
shown that FGF21 enhanced in vivo insulin sensitivity through a combination of reduced
adiposity and mechanisms that are independent of adiposity (10). Collectively, these studies
made a compelling case that FGF21 mediates the thermogenic and insulin-sensitizing effects
of dietary MR (10).
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Although previous studies have shown that pharmacological administration of FGF21
produces profound effects on a number of metabolic responses, the present studies address
the biological significance of the physiological increases in circulating FGF21 that are
produced by dietary MR. The importance of this question stems from the attractive
possibility of producing beneficial metabolic responses through dietary modulation of
FGF21. The initial descriptions of FGF21 provided compelling evidence that it is a powerful
metabolic regulator in the context of glucose homeostasis, lipid metabolism, and energy
balance (11–17), but controversy remains about how FGF21 signaling is anatomically
organized to produce its multiple physiological effects. This question also extends to dietary
MR, where current evidence supports the role of FGF21 as an important mediator of the
effects of the diet. Using cohorts of mice with tissue-specific deletion of an essential coreceptor of FGF21 signaling, we establish that loss of FGF21 signaling in the brain
compromises the ability of dietary MR to remodel adipose tissue and increase EE, but not its
ability to affect hepatic gene expression.

Materials and Methods
Experimental Protocols, Diets, and Animals
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All experiments were approved by Pennington Biomedical Research Center Institutional
Animal Care and Use Committee based on guidelines approved by the National Research
Council, Animal Welfare Act, and PHS Policy on humane care and use of animals in
scientific research. Mice were singly housed in shoebox cages with corncob bedding. Using
the feeding paradigm described previously (18, 19), 5 week-old male mice received either a
purified diet containing 0.86% methionine and no cysteine (Con group) or methionine
restricted to 0.17% and no cysteine (MR group). The diets were formulated as extruded
pellets by Dyets Inc. (Bethlehem, PA) and provided ad libitum. The energy content of Con
and MR diets was 15.96 kJ/g, with 18.9% of energy from fat (corn oil), 64.9% from
carbohydrate, and 14.8% from a custom mixture of L-amino acids. The amino acid content
Obesity (Silver Spring). Author manuscript; available in PMC 2021 October 01.
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of the diet on a weight basis was 14.1%. Details of diet composition were provided
previously (19). Housing temperature was maintained at 22–23° C for Experiments 1 and 2
and at 28° C in Experiment 3. Lights were on 12 h cycle from 7 AM-7 PM.
Food intake was measured each week by weighing food at the beginning of the feeding
interval and then weighing the remaining food. Bedding was sifted through wire mesh to
collect wasted food. Additionally, body weight and composition were assessed at weekly
intervals using nuclear magnetic resonance (NMR) spectroscopy (Bruker Minispec,
Billerica, MA). Animals were fasted for four hours prior to euthanasia and tissue collection.
Trunk blood was collected for serum analyses and tissues were harvested and snap frozen in
liquid nitrogen until analysis. Fasting serum insulin (Millipore; Billerica, MA) and FGF21
(R&D Systems; Minneapolis, MN) were determined via enzyme-linked immunosorbent
assays (ELISA) according to the manufacturers’ protocol.

Author Manuscript

β-klotho floxed (Klbfl/fl) mice on a B6 background were provided by Dr. Steven Kliewer
(16, 20) and tissue-specific knockouts of β-klotho were generated by crossing female
Klblfl/fl mice with male Klblfl/fl mice carrying either Adiponectin-Cre (adipose-specific,
Jackson Labs, Stock No. 028020) or CamK2a-Cre alleles (brain-specific (21)). The resulting
litters contained Cre positive (Klbfl/(Adip) or Klbfl/(CamK2a)) or Cre negative littermate
controls (Klbfl/fl of equivalent genetic background to serve as control mice.
Experiment 1
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Four-week old male Klbfl/fl or Klbfl/(Adip) mice (n=26–28 per genotype) were housed at 22–
23° C and given Con diet for one week prior to being adapted to the Promethion indirect
calorimetry (IDC) system (Sable Systems, Las Vegas, NV) for three days. On day 3, half the
mice of each genotype were randomized to receive the MR diet while the other half
continued on the Con diet. Mice remained in the calorimeter for an additional nine days to
measure their responses to the respective diets before being returned to home cages.
Thereafter, animals were maintained on assigned diets for eight weeks. Body weight,
composition, and food intake were assessed at weekly intervals as described above. Animals
were re-acclimated to the Promethion system for one week, followed by five days of VCO2
and VO2 measurements for calculation of energy expenditure (EE). Animals were returned
to their home cages for one week of recovery prior to euthanasia and tissue harvest.
Experiment 2
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Four-week old male Klbfl/fl or Klbfl/(CamK2a) mice (n=16–20 per genotype) were housed at
22–23° C and given Con diet for one week prior to being randomized to receive Con or MR
diet for the following eight weeks. Body weight, composition, and food intake
measurements were made at weekly intervals as described above. Animals were then
acclimated to the Promethion system for one week, followed by five days of VCO2 and VO2
measurements for calculation of energy expenditure (EE). Animals were returned to their
home cages for one week prior to euthanasia and tissue harvest.
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Four-week old male Klbfl/fl or Klbfl/(Adip) mice and Klbfl/fl or Klbfl/(CamK2a) mice (n=16 per
genotype) were given Con diet and adapted to housing at 28° C for one week prior to being
randomized to receive Con or MR diet for the following eight weeks. This was done to lower
basal expression of UCP1 in mice on the Con diet and provide a more sensitive test of MRdependent increases in UCP1 expression. Thereafter, the mice were euthanized and brown
adipose tissue (BAT) was harvested and snap frozen.
Perfusion and Immunohistochemistry
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At study’s end, a subset of animals from Experiments 1 and 2 were perfused for
immunohistochemical analyses. Mice were injected with Socumb (Henry Schein Medical,
Mellville, NY) to induce a deep state of anesthesia. Then mice were perfused with PBS
using a peristaltic pump, followed by 10% formalin as a tissue fixative. Inguinal white
adipose tissue (IWAT) samples were harvested, stored in 10% formalin, and then embedded
in paraffin, cut into 5 μm sections, and sequentially stained for UCP1 and wheat germ
agglutinin (WGA) as previously described (4). The slides were imaged using a Hamamatsu
Nanozoomer slide scanner using a DAPI/FITC/TxRed filter set and the percentage of WGA
stained cells expressing UCP1 was measured using Visiopharm software (Visiopharm,
H0rsholm, Denmark) as before (4).
RNA Isolation and Gene Expression
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Total RNA was isolated using the RNeasy Mini Kit (QIAGEN, Inc.; Valencia, CA) and 1 μg
of total RNA was used for reverse transcription to produce cDNA. Gene expression was
measured via quantitative real-time PCR, and mRNA concentrations were normalized to
cyclophilin expression, and expressed as fold-change relative to Klbfl/fl mice on the Con
diet. The primers used for all PCR reactions are provided in online supporting information
Table 1.
Western Blotting
Whole cell lysates of BAT were prepared by homogenizing tissue in buffer (150 mM NaCI,
1 mM EDTA, 1 mM EGTA, 10 mM Tris, 1% Triton x-100, 0.5% NP-40) and protein
quantitated by Lowry assay. Three μg were loaded per lane, separated by SDS-PAGE, and
transferred to polyvinylidene fluoride membranes (BioRad; Hercules, CA). Expression of
UCP1 was measured as previously described and standardized to PDC-E2 (3). Blots were
developed using enhanced chemiluminescence and band densities determined using Image J
software.

Author Manuscript

Analysis of Energy Expenditure
VO2 is expressed as liters (L) of O2 consumed per h, while Respiratory Exchange Ratio
(RER) is the ratio of VCO2 produced to VO2 consumed. EE was calculated as (VO2 ×
(3.815 + (1.232 × RER)) × 0.96 kCal/h) × 4.019 kJ/kCal, and expressed as kJ/h/mouse.
Group differences in 24 h EE (kJ/h/mouse) at study’s end were compared using Analysis of
Covariance (ANCOVA) (JMP Software, Version 12; SAS Institute Inc., Cary, NC) to
calculate least squares means that accounted for variation in EE attributable to differences in
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lean mass, fat mass, and activity among the mice. The initial diet-dependent change in
daytime and nighttime EE was calculated by subtracting the daytime and nighttime EE of
each group prior to diet changes from the day and night time measures of EE during the nine
days after initial exposure to the MR diet on day 0. The diet-induced change in mean
daytime and nighttime EE measurements were compared to the corresponding measures of
EE in mice of each genotype on the Con diet using a repeated measures two-way ANOVA
and the Bonferroni correction to account for multiple comparisons.
Statistical Analysis

Author Manuscript

Body weight, body composition, food intake, gene expression, and protein expression levels
were analyzed using two-way ANOVA (GraphPad Prism; San Diego, CA) with genotype
and diet as main effects. Group differences in EE (kJ/hr/mouse) were compared using as
described previously ANCOVA (3). The least square means ± SEM for each genotype x diet
interaction were compared using two-way ANOVA and the significance of the model effects
and interaction were tested using residual variance calculated by the ANCOVA. Protection
against type I errors was set at 5% (α = 0.05).

Results
Experiment 1
The initial body weight and composition of control (Klbfl/fl) and adipocyte-specific β-klotho
knockout mice (Klbfl/(Adip)) did not differ, and both genotypes responded to dietary MR with
a comparable decrease in body weight and adiposity over the duration of the study (Table 1).
The MR diet also produced comparable increases in energy intake and serum FGF21 in both
genotypes, and a comparable decrease in fasting insulin (Table 1).

Author Manuscript
Author Manuscript

The effects of MR on EE were examined at the beginning and end of Experiment 1. At the
beginning of the experiment when all mice were on the Con diet, the transition between
daytime and nighttime EE was comparable between Klbfl/fl and Klbfl/(Adip) mice (Figure
1A). This pattern continued for 3 days after introduction of dietary MR to half the mice, but
between days 4 and 5, a larger nighttime increase in EE in both Klbfl/fl and Klbfl/(Adip) mice
on the MR diet begins to emerge (Figure 1A). Between days 5 to 9, both daytime and
nighttime EE in Klbfl/fl and Klbfl/(Adip) mice on the MR diet are increased relative to mice of
each genotype on the Con diet (Figure 1A). To better assess the timing of diet-dependent
effects on EE after introduction of dietary MR, the daytime and nighttime EE during the 3
day run-in period were subtracted from the daytime and nighttime means of each group after
introduction of MR and plotted as diet-dependent changes in EE from days 0 through 8.
Figure 1B shows that daytime EE in the Klbfl/fl and Klbfl/(Adip) mice on the Con diet did not
change appreciably during this period. Daytime EE in the Klbfl/fl and Klbfl/(Adip) mice on the
MR diet was similar to mice on the Con diet from day 0 to 4, but on day 5 the daytime EE
became significantly higher in Klbfl/(Adip) mice on the MR diet compared to Con (Figure
1B). On days 6 to 8, daytime EE in Klbfl/fl and Klbfl/Adip) mice on the MR diet was higher
than mice of each genotype fed Con diet. A similar pattern emerges with respect to
nighttime EE, where Klbfl/fl and Klbfl/(Adip) mice on both diets were initially comparable
(Figure 1C). However, by day 4, nighttime EE in Klbfl/(Adip) mice on the MR diet is

Obesity (Silver Spring). Author manuscript; available in PMC 2021 October 01.

Forney et al.

Page 6

Author Manuscript

significantly higher than Klbfl/(Adip) mice on Con diet. By day 5 and all subsequent days,
nighttime EE in Klbfl/fl and Klbfl/(Adip) mice on MR diet is higher than mice of both
genotypes on the Con diet (Figure 1C). Relative to mice on the Con diet at study’s end,
dietary MR produced a slightly smaller increase in total EE in Klbfl/(Adip) mice than Klbfl/fl
mice (Figure 1D). However, viewed collectively, the effects of dietary MR on measures of
energy balance were unaffected by the absence of FGF21 signaling in adipose tissue.
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The biochemical and transcriptional effects of the diets in IWAT and liver from Experiment
1 are illustrated in Figures 2A, 2B, and 4A. Dietary MR produced a comparable increase in
mRNA of thermogenic genes associated with fat oxidation (e.g., Ucp1, Cox7a, Cox8b) in
IWAT of both Klbfl/fl and Klbfl/(Adip) mice (Figure 2A). To assess the extent of remodeling
of IWAT by dietary MR, dual-label immunohistochemistry was used to measure changes in
the number of cells expressing UCP1 within the entire inguinal depot. This was
accomplished by staining cell membranes with WGA (green) and mitochondrial UCP1 (red)
in replicate sections of the depot (Figure 2B). An unbiased imaging algorithm was used to
count the total number of cells within each section and the total number of cells also
expressing UCP1 in the same section. The median number of cells expressing UCP1 in
Klbfl/fl and Klbfl/(Adip) mice on the Con diet was comparable and dietary MR produced a
similar increase in the number of cells expressing UCP1 in each genotype (Figure 2B).
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In liver, the MR diet reproduced its previously reported activation of Fgf21 gene expression,
down regulation of Scd1 mRNA, and increase in activating transcription factor 4 (ATF4)
target genes (9, 22) (Figure 4A). All four of these transcriptional effects of MR were
comparable in liver of Klbfl/fl and Klbfl/(Adip) mice. Collectively, the absence of β-klotho
from adipose tissue did not compromise the ability of dietary MR to produce its expected
transcriptional effects in WAT or liver.
Experiment 2
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The initial body weight and composition of control (Klbfl/fl) and brain-specific β-klotho
knockout mice (Klbfl/(CamK2a)) did not differ, and both genotypes responded to dietary MR
with a comparable decrease in body weight and adiposity over the duration of the study
(Table 1). Energy intake per mouse was comparable between Klbfl/fl and Klbfl/CamK2a)mice
on the Con diet, but MR produced opposite effects on energy intake in the two genotypes.
MR increased intake in Klbfl/fl mice over the course of the study whereas energy intake in
Klbfl/CamK2a) mice on the MR diet was unchanged or slightly decreased (Table 1). When
energy intake is scaled to body weight, energy intake per gram body weight in Klbfl/CamK2a)
mice on Con and MR diets is nearly identical, indicating that the loss of weight and
adiposity in Klbfl/CamK2a) mice on the MR diet is explained primarily by their reduction in
food intake (Table 1). In contrast, the response of control mice (Klbfl/fl) to MR was a large
increase in energy intake per g body weight, indicative of weight loss driven by an increase
in EE (Table 1). These predictions are supported by measurements of EE showing that MR
significantly increased EE in Klbfl/fl mice, but had no effect on EE in Klbfl/(CamK2a) mice
(Figure 1E). Interestingly, EE in Klbfl/(CamK2a) mice on the Con diet was lower than EE in
Klbfl/fl mice on the Con diet (Figure 1E). Figure 1F shows that β-klotho mRNA levels were
below the limits of detection in the Klbfl/(CamK2a) mice.
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The absence of β-klotho in the brain did not compromise the ability of dietary MR to
increase serum FGF21 in Klbfl/fl and Klbfl/(CamK2a) mice (Table 1). Although dietary MR
produced reductions in adiposity in Klbfl/fl and Klbfl/(CamK2a) mice through opposite effects
on energy intake and EE, the comparable MR-dependent reductions in adiposity in Klbfl/fl
and Klbfl/(CamK2a) mice translated into comparable reductions in fasting insulin (Table 1).
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Dietary MR produced a 5-fold induction of Ucp1 mRNA in IWAT of Klbfl/fl mice relative to
the Con diet, and smaller but significant increases in Cox7a and Cox8b mRNA (Figure 2C).
The MR diet increased Ucp1 mRNA by ~2-fold in IWAT of Klbfl/(CamK2a) mice, but the
effect of the diet on Cox7a and Cox8b mRNA was not significant (Figure 2C). Evaluation of
MR-dependent changes in IWAT UCP1 protein expression showed that the diet produced a
3-fold increase in the number of inguinal adipocytes expressing UCP1 in Klbfl/fl mice but
did not increase UCP1 expressing adipocytes in Klbfl/CamK2a) mice (Figure 2D). In contrast
to the effects in IWAT, dietary MR produced comparable induction of Fgf21 mRNA, Psat1
mRNA, and Asns mRNA in liver of Klbfl/fl and Klbfl/(CamK2a) mice, and a comparable
reduction in Scd1 mRNA (Figure 4B). Collectively, these findings indicate that brainspecific deletion of β-klotho blocks the ability of dietary MR to increase EE and remodel
IWAT, but not its ability to modulate hepatic gene expression.
Experiment 3
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Klbfl/fl ,Klbfl/(Adip), Klbfl/fl and Klbfl/(CamK2a) mice were adapted to 28° C to lower
temperature-dependent sympathetic activity before examining whether deletion of
adipocyte-specific or brain-specific signaling by FGF21 would compromise the ability of
MR to induce UCP1 protein expression in BAT. UCP1 expression was comparable in BAT
from Klbfl/fl and Klbfl/(Adip) mice on the Con diet, and dietary MR produced a similar 2.2fold induction of UCP1 in both genotypes (Figure 3A). Basal expression of UCP1 was also
similar in BAT from Klbfl/fl and Klbfl/(CamK2a) mice on the Con diet, and dietary MR also
produced a significant increase in BAT UCP1 in Klbfl/fl mice (Figure 3B). In contrast,
dietary MR failed to increase UCP1 in BAT from Klbfl/(CamK2a) mice (Figure 3B),
supporting the view that FGF21 signaling in the brain, but not adipose tissue, is essential for
MR-dependent induction of UCP1.

Discussion

Author Manuscript

Dietary MR produces a reproducible series of transcriptional, physiological, and behavioral
responses that reduce fat deposition, enhance insulin sensitivity, reduce circulating lipids,
and both prevent and reverse diet-induced obesity (2, 5–7, 23–28). Although FGF21 has
been shown to play an essential role as a mediator in many of these biological responses to
dietary MR (10), a major unresolved goal has been to understand the anatomical
organization of FGF21 signaling in terms of how it produces the component responses of
this complex metabolic phenotype. In initial reports, the biological responses to FGF21 were
catalogued in studies where FGF21 was infused at high doses or increased via transgenic
overexpression, so it was initially unclear whether the smaller but physiological increases in
FGF21 produced by MR (5) would be sufficient to elicit all of the responses produced by
pharmacological levels of the hormone (29). However, many if not most of the metabolic,
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transcriptional, and signaling effects produced by FGF21 are fully reproduced by dietary
MR (2, 3, 5, 7, 24). For example, like MR, FGF21 directly increases adiponectin secretion
from adipocytes (30), increases lipogenic gene expression in WAT (11), promotes browning
of WAT (31), and increases thermogenic gene expression in BAT and WAT (31). Dietary MR
also produces significant browning of WAT (2, 4, 7) and given the increased glucose uptake
and utilization associated with browning (32), it is attractive to suggest that MR is
functioning through this mechanism to increase insulin sensitivity in WAT. However, recent
reports argue that the glycemic improvements produced by FGF21 in WAT are independent
of browning (33, 34) and are dependent on direct effects of FGF21 in adipose tissue (5, 13,
20, 35). This view is also supported by studies showing that pegylated FGF21, which is too
big to penetrate the CNS, is fully effective in normalizing glucose utilization in insulin
resistant states (36). Collectively, these findings support the view that at least some of the
effects of dietary MR are mediated by direct effects of FGF21 signaling in adipocytes.
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FGF21 also acts centrally, and although the specific CNS regions where FGF21 is acting
remain ill-defined, evidence is strong that FGF21 increases energy expenditure by increasing
SNS outflow to adipose tissue (12, 16, 37, 38). We have shown that dietary MR increases
core temperature, energy expenditure, and thermogenic function of BAT and WAT through
increases in SNS stimulation of adipose tissue (1, 2). However, we have also shown that
dietary MR produces increases in insulin sensitivity that are independent and additional to
the enhanced insulin signaling that accrues from MR-induced weight loss and reduced
adiposity (10). When undertaking the present work, our initial hypothesis was that the MRinduced increase in FGF21 acts through a combination of direct effects in adipose tissue and
centrally to mediate the increase in SNS-dependent browning and thermogenesis. We were
uncertain whether direct FGF21 signaling in adipose tissue synergized with SNS-dependent
input to enhance browning and thermogenesis. Recent work supported this possibility by
proposing that SNS-dependent increases in adipocyte expression of FGF21 produced a
paracrine effect that enhanced browning of WAT and activation of thermogenesis in BAT
(31, 38). The only evidence obtained to support this view was the small but significant
induction of UCP1 mRNA expression by MR in IWAT of Klbfl/(CamK2a) mice (Fig. 2C). MR
produced a large 20-fold induction of FGF21 in these mice so perhaps the hepatic hormone
was able to act directly on inguinal adipose tissue and increase expression of this
thermogenic gene. However, the other two thermogenic genes measured in these samples
were unaffected. More importantly, immunohistochemical analysis of IWAT provided no
evidence that MR was able to induce UCP1 expression in this tissue (Fig. 2D). Therefore,
using genetic tools to alternatively delete FGF21 signaling in adipose tissue (e.g.,
Klbfl/(Adip)) and the CNS (e.g., Klbfl/(CamK2a)), we found little evidence that FGF21
signaling in adipose tissue played any significant role in MR-induced browning of adipose
tissue or increases in EE. In contrast, deletion of FGF21 signaling in the brain fully blocked
the ability of dietary MR to increase food intake, increase EE, and induce expression of
UCP1 in BAT. These results mirror our previous findings in FGF21-null mice (10),
including the slight negative effect on energy intake that produced the weight loss and
decrease in adiposity observed in the Klbfl/(CamK2a) mice here. This similarity across two
models argues against a non-specific effect of the diet being produced in any single mouse
line.
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An important unresolved question from the CamK2a-Cre model is exactly where in the brain
FGF21 signaling is being deleted. The initial work showed that CamK2a-Cre targeted
primarily glutamatergic neurons in the forebrain (16, 20, 21), and neurons within the
hypothalamic suprachiasmatic nucleus or paraventricular nucleus (16, 39–41). The latter
sites are most associated with known effects of FGF21-dependent signaling. It seems likely
that FGF21 may signal in multiple brain areas through redundant systems to coordinate
responses involving food intake and activation of the SNS. Much additional work will be
needed to understand how FGF21 mediates the coordination of these important survival
responses. However, the present work makes a compelling case that FGF21 signaling in the
brain is essential in mediating the responses to dietary MR on energy balance.

Author Manuscript

Lastly, it is important to note that the ability of dietary MR to modulate hepatic gene
expression was fully intact in mice with FGF21 signaling alternatively deleted in adipose
tissue or the brain. This included FGF21 itself, the lipogenic gene, SCD1, and two ATF4sensitive genes shown previously to be upregulated by dietary MR (7, 8). We previously
found that the ability of dietary MR to downregulate lipogenic gene expression was fully
intact in FGF21 null mice (10). These findings support the view that at least some of the
transcriptional effects of dietary MR in the liver are independent of transcriptional activation
of hepatic FGF21 and likely involve direct essential amino acid sensing and signaling
mechanisms. Viewed collectively, the model that best explains the complex phenotype
produced by dietary MR involves a combination of direct sensing of reduced dietary
methionine by the liver and secondary effects of transcriptionally activated FGF21 acting
primarily in the CNS.

Supplementary Material
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Refer to Web version on PubMed Central for supplementary material.
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Study Importance
What is already known about this subject?
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•

Restriction of dietary methionine to 0.17% reduces adiposity, enhances
browning of white adipose tissue, increases energy expenditure, and improves
insulin sensitivity by increasing hepatic transcription and release of hepatic
FGF21.

•

The increased circulating FGF21 is thought to act both centrally and through
direct effects in peripheral tissues to produce these integrated physiological
responses.

•

Methionine restriction produces remodeling of white adipose tissue through a
FGF21-dependent mechanism, but it is unclear where FGF21 acts to produce
these effects.

What does your study add?

Author Manuscript

•

Tissue-specific deletion of the FGF21 co-receptor in adipose tissue does not
abrogate the ability of dietary methionine restriction to increase energy
expenditure and reduce fat deposition.

•

Tissue-specific deletion of the FGF21 co-receptor from the brain produced
mice that were unable to respond to the effects of methionine restriction on
energy expenditure and remodeling of adipose tissue.

•

The effects of methionine restriction on hepatic gene expression were intact in
both models, supporting a mechanism that directly links detection of reduced
methionine to transcriptional mechanisms in the liver.

Potential of work to change clinical practice
•

Given that a major goal of our work is to develop therapeutic diets that reduce
obesity by reducing dietary methionine, it is important to establish the tissuespecific roles of endocrine mediators of dietary methionine restriction in preclinical studies.

•

Using cohorts of mice with the co-receptor of FGF21 deleted in either adipose
tissue or the brain, we establish that the increase in FGF21 produced by
dietary MR acts primarily in the brain to produce its physiological responses.
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Figure 1 - Assessment of acute and chronic effects of dietary MR on EE in Control mice (Klbfl/fl),
mice with adipocyte-specific Klb knockout (Klbfl/(Adip)), or mice with brain-specific Klb
knockout (Klbfl/(CamK2a)).
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EE was measured via indirect calorimetry (IDC) during the first 12 days of the experiment in
sixteen Klbfl/fl and sixteen Klbfl/(Adip) mice on Con and MR diets and for the last 7 days of
the experiment in each genotype x diet combination. At the beginning of Experiment 1,
Control mice (Klbfl/fl) and adipocyte-specific Klb knockout mice (Klbfl/(Adip)) were placed
in the calorimeter chambers for 4 days with all animals receiving the control diet (Con).
Then on day 0, half the mice of each genotype were switched to the MR diet while the other
half of the mice continued on the Con diet. EE was measured for the next 9 days (Fig. 1A).
Error bars are omitted for clarity in Fig. 1A. To better assess the timing of diet-dependent
effects on EE after introduction of dietary MR, the mean daytime and nighttime EE during
the 3 day run-in period was subtracted from the daytime and nighttime means for each
successive 24 h period for each group after introduction of MR, and plotted as dietdependent changes in daytime and nighttime EE from days 0 through 8. Figs. 1B and 1C
show the change over time in daytime mean EE (Fig. 1B) and nighttime mean EE (Fig. 1C)
in the Klbfl/fl and Klbfl/(Adip) mice on the Con and MR diets. Mean daytime and nighttime
EE in the 4 groups were compared using a repeated meaures two-way ANOVA and means
annotated with an asterisk on specific days differ from their corresponding genotype on the
Con diet on that day at P<0.05. At the end of Experiments 1 (Fig. 1D) and 2 (Fig. 1E), all
mice in each experiment were re-acclimated to the IDC chambers for one week, followed by
five days of VCO2 and VO2 measurements for calculation of total energy expenditure (EE).
Mean 24 h EE was calculated from the measurements made during the last 5 days of each
study and compared by ANCOVA as described in Materials and Methods. All values are
expressed as mean ± SEM for 8 mice of each genotype × diet combination. In Figs. 1D and
1E, least square means for 24 h EE not sharing a common letter differ at p < 0.05. In Fig. 1F,
the transcript abundance of β-klotho was measured in the diencephlon using hypoxanthine
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guanine phosphoribosyl transferase (Hrpt) as a denominator and determined to be
undetectable.
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Figure 2 - Transcriptional markers of browning and UCP1 protein expression in IWAT from
Experiments 1 and 2.
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Effects of MR on thermogenic gene expression in IWAT were measured via qPCR and
expressed as fold-change relative to Klbfl/fl mice on the Con diet in Experiment 1 (Fig. 2A)
and Klbfl/fl mice on the Con diet in Experiment 2 (Fig. 2D). Con - control; MR - methionine
restricted diets; Klb - β-klotho; Ucp1 - uncoupling protein 1; Cox7a - cytochrome C oxidase
subunit 7A; Cox8b - cytochrome C oxidase subunit 8B. Means for fold-change of gene
expression denoted with an asterisk (*) differ from their corresponding genotype on the Con
diet at p < 0.05. Effect of dietary MR on morphology and UCP1 expression in IWAT
sections from Klbfl/fl mice and adipocyte-specific Klb knockout mice (Klbfl/(Adip)) from
Experiment 1 (Fig. 2B) and in IWAT sections from Klbfl/fl mice and brain-specific Klb
knockout mice (Klbfl/(CamK2a)) from Experiment 2 (Fig. 2D). IWAT sections from each
genotype × diet combination were stained for UCP1 (red) and wheat germ agglutinin (green)
for cell membranes. The percentage of the total cells in each section expressing UCP1 was
determined in replicate sections (n=4) from each genotype × diet combination using
Visiopharm software Cell Prolifer Software as described in the Methods. The percentage of
UCP1-expressing cells in each group is presented in the accompanying bar graphs of Figs.
2B and 2D. Diet-induced differences within each genotype are denoted with an asterisk
(P<0.05).
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Figure 3 - Effect of dietary MR on UCP1 expression in BAT of Control mice (Klbfl/fl), mice with
adipocyte-specific Klb knockout (Klbfl/(Adip), or mice brain-specific Klb knockout
(Klbfl/(CamK2a)) housed at 28° C.
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Klbfl/fl or Klbfl/(Adip) mice and Klbfl/fl or Klbfl/(CamK2a) mice were provided the Con diet and
adapted to housing at 28° C for one week prior to being randomized to receive Con or MR
diet for the following eight weeks. Thereafter, the mice were euthanized and UCP1
expression was measured by Western blot in BAT whole cell extracts from Klbfl/fl and
Klbfl/(Adip) mice (Fig. 3A) and in Klbfl/fl or Klbfl/(CamK2a) mice (Fig. 3B) on the two diets.
The mitochondrial marker, PDC-E2 (pyruvate dehydrogenase dihydrolipoamide
acetyltransferase) was used as a loading control and UCP1 expression was determined in 5
to 6 replicates per group and expressed as the ratio of UCP1 to PDC-E2 as before (10). Figs.
3A and 3B show representative blots of samples from each experiment.
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Figure 4 - Transcriptional responses to dietary MR in livers from Control mice (Klbfl/fl), mice
with adipocyte-specific Klb knockout (Klbfl/(Adip)), or mice brain-specific Klb knockout
(Klbfl/(CamK2a)).
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Hepatic gene expression was measured via qPCR in livers harvested from Klbfl/fl and
Klbfl/(Adip) mice on Con and MR diets from Experiment 1 (Fig. 4A) and from Klbfl/fi and
Klbfl/(CamK2a) mice on Con and MR diets from Experiment 2 (Fig. 4B). Klb - β-klotho;
Fgf21 - fibroblast growth factor 21; Scd1 - stearoyl CoA desaturase 1; Psat1 - Phosphoserine
Aminotransferase 1; Asns - asparagine synthaseWithin each experiment, gene expression
was analyzed using a two way ANOVA with genotype and diet as main effects and residual
variance used as the error term. All values are expressed as mean ± SEM for 8 mice of each
genotype x sex. Means for fold-change of gene expression denoted with an asterisk (*)
indicates significant difference from the Con within genotype at p < 0.05.
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Energy balance and serum hormone parameters for mice with β-Klotho deleted in adipose tissue (Klbfl/fl x

AdipCRE) or the central nervous system (CNS) (Klbfl/fl x CamK2aCRE) and fed control or methioninerestricted diets for 11 wks

A

Experiment 1
Klbfl/fl

Experiment 2
Klbfl/(Adip)

Klbfl/fl

Klbfl/(CamK2a)

Control

MR

Control

MR

Control

MR

Control

MR

Initial BW (g)

19.1 ± 0.4a

19.7 ± 0.3a

18.9 ± 0.6a

19.2 ± 0.4a

15.7 ± 0.6a

16.2 ± 0.9a

16.5 ± 0.4a

17.1 ± 0.6a

Final BW (g)

29.0 ± 0.9a

23.4 ± 0.4b

26.3 ± 0.7a

22.4 ± 0.5b

29.5 ± 1.0a

24.5 ± 0.8b

30.5 ± 1.0a

24.1 ± 0.5b

B

10.2 ± 0.3a

9.9 ± 0.3a

9.7 ± 0.4a

9.9 ± 0.3a

10.4 ± 0.5a

11.0 ± 0.9a

11.6 ± 0.5a

12.6 ± 0.7a

B

14.8 ± 0.6a

11.9 ± 0.2b

12.0 ± 0.6b

9.9 ± 0.3c

15.1 ± 1.2a

12.4 ± 0.9b

14.7 ± 0.7a

10.7 ± 0.7b

Initial Fat Mass
(g)

1.94 ± 0.08a

1.95 ±
0.09a

1.83 ± 0.09a

1.90 ±
0.08a

1.63 ± 0.11a

1.78 ±
0.19a

1.91 ± 0.13a

2.15 ±
0.20a

Final Fat Mass
(g)

4.29 ± 0.31a

2.78 ±
0.07b

3.16 ± 0.21c

2.22 ±
0.09d

4.45 ± 0.32a

3.04 ±
0.18b

4.48 ± 0.26a

2.58 ±
0.21c

47.2 ± 1.0a

52.8 ± 1.5b

48.9 ± 1.0a,b

51.7 ±
1.6a,b

44.1 ± 1.8a

53.2 ± 1.6b

40.8 ± 0.7a

39.0 ± 0.8a

Energy Intake
(kJ/d/g)

1.98 ± 0.05a

2.51 ±
0.05b

2.12 ± 0.05a

2.49 ±
0.03b

1.93 ± 0.05a

2.43 ±
0.06b

1.77 ± 0.02c

1.77 ±
0.02c

Serum Insulin
(ng/ml)

3.06 ± 0.74a

0.57 ±
0.04b

2.04 ± 0.61a

0.61 ±
0.09b

3.45 ± 0.79a

1.48 ±
0.37b

3.03 ± 0.30b

0.75 ±
0.16b

Serum FGF21
(ng/ml)

6.62 ± 2.59a

15.1 ± 3.1b

7.1 ± 1.3a

19.2 ± 3.6b

1.2 ± 0.6a

7.8 ± 2.7b

0.7 ± 0.1a

19.1 ± 1.8b

Initial %
Adiposity
Final %
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Adiposity

C

Energy Intake
(kJ/d/mouse)

C
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A

Body weight, adiposity, energy intake, serum insulin, and serum FGF21 were measured as described in the Materials and Methods, and compared
by two-way analysis of variance using Genotype and Diet as main effects. Least squares means were compared using residual variance as the error
term and presented as mean ± SEM (n=13–16 mice/group for Experiment 1 and n=8–10 mice/group for Experiment 2). Within each experiment,
means of each variable annotated with different superscripts differ at P < 0.05.

B

Body composition was measured by NMR as described in the Materials and Methods and % adiposity was calculated as fat mass / body weight x
100.

C

The average food intake less spillage was determined over a 24 h period in mice of each genotype on each diet, converted to kJ, and expressed per
mouse or per unit of body weight. Means represent average daily energy intake over the entire study and were compared by two-way ANOVA as
described above.
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